Mangoceuticals (MGRX) Shares Fall 12% After Hours: Here's Why
Mangoceuticals shares fall 12% after hours despite a $2.5 million strategic investment in its antiviral IP subsidiary.
Share
Why It Matters
Mangoceuticals got $2.5 million for its antiviral business, but shares dropped 12% anyway. When a stock falls despite good news, it hints that investors worried about something else.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.